The Oncology Institute, Inc. (TOIIW) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 111.33M |
| Enterprise Value | 104.05M |
| P/E Ratio | -21.55 |
| PEG Ratio | 0.32 |
| Price/Sales Ratio | 1.1 |
| Price/Book Ratio | -26.74 |
| Enterprise/Revenue | 1.21 |
| Enterprise/EBITDA | -32.48 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -0.06 |
| Operating Margin | -0.04 |
| Return On Assets | -0.2 |
| Return On Equity | 2.1 |
| Revenue | 502.73M |
| Revenue/Share | 5.7 |
| Gross Profit | 69.49M |
| EBITDA | -42.52M |
| Net Income | -60.61M |
| Diluted EPS | -0.54 |
| Total Cash | 41.09M |
| Total Cash/Share | 0.4 |
| Total Debt | 104.48M |
| Total Debt/Equity | -4.19 |
| Current Ratio | 1.36 |
| Book Value Per Share | -0.24 |
| 52-Week Change | -63.57 |
| 52-Week High | 0.18 |
| 52-Week Low | 0.05 |
| Moving Average 50 Days | 0.05 |
| Moving Average 200 Days | 0.1 |
| Average Volume | 10,300 |
| Shares Outstanding | 98.57M |
| % Held by Institutions | 0.38 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |